drugset / Trial / NCT01040793
Effect of Treatment BI 1744 CL (5 and 10 mcg) Versus Placebo on Exercise Endurance Time During Constant Work Rate Cycle Ergometry II
RandomizedCrossoverDouble-blindTreatment
Summary
To compare the effects of BI 1744 CL versus placebo on exercise tolerance after 6 weeks of treatment in patients with Chronic Obstructive Pulmonary Disease.
Timeline
- Start
- 2010-01
- Primary completion
- 2011-04
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Olodaterol | Small molecule | 5 ug | Inhaled |
| Subject | Olodaterol | Small molecule | 10 ug | Inhaled |